(1) have a DSM-V diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform confirmed by diagnostic assessment and medical record review
(2) between the ages of 18-50
(3) stabilized on psychotropic medication as indicated by no changes to the primary psychiatric medication in the last month
(4) able to read and speak fluent English at a sixth grade level or higher for purposes of informed consent and cognitive testing
For Clubhouse members, they must be a first-time, newly enrolled member
You may not be if
(1) had previous membership at a Clubhouse (Magnolia or elsewhere)
(2) have a current severe substance use disorder
(3) have persistent suicidal or homicidal behavior
(4) a co-occurring diagnosis of an intellectual or learning disability or neurodevelopment condition (e.g., Autism; based on chart review)
(5) had recent psychiatric instability requiring hospitalization in the past month;
(6) history of a traumatic brain injury (TBI; based on record review)
(7) contraindicators for MRI (e.g., pacemaker, claustrophobia)
Participants in the usual care will be excluded if they are a current Clubhouse member or join a Clubhouse during participation in this research
Clareo Health | REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
